Experimental and Therapeutic Medicine · 2013 · 29 citations · 12 references
MedicineNeurologyRadiologyDiagnostic ImagingDiagnostic RadiologyNeuroradiologyBrain ImagingDemyelinating DiseasesDemyelinating DisordersMagnetic Resonance ImagingNeurologic ImagingDisease FociEarly DiagnosisMagnetic ResonanceMagnetic Resonance Image FeaturesMagnetic Resonance Imaging Lesion DetectionNeuroimaging DiagnosticsWhite Matter InvolvementWhite Matter Lesions
The aim of this study was to explore the diagnostic value of magnetic resonance imaging (MRI) for levamisole-induced demyelinating leukoencephalopathy. The clinical features and MRI findings of 15 patients with levamisole-induced demyelinating leukoencephalopathy were retrospectively analyzed. The abnormality rate of the patients was demonstrated to be 100% by MRI, and scattered multiple cerebral foci were observed in all of the patients. The majority of the foci were located at the centrum ovale, peri-lateral cerebral ventricles and basal ganglia, while the remainder were located in the brain stem and cerebellum, as well as in the white matter regions of the temporal, frontal, apical and occipital lobes. In addition, mottling and ring-shaped enhancements were observed. The study demonstrated that MRI effectively displays demyelinating leukoencephalopathy, and that the combination of MRI with the medical history of the patient is of significance for the early diagnosis, differentiation and treatment of demyelinating leukoencephalopathy.
12
Basic and Clinical Pharmacology
Lemuel B. Wingard · Anesthesia & Analgesia · 1983 · 637 citations
Multifocal inflammatory leukoencephalopathy with 5‐fluorouracil and levamisole
C. Christopher Hook, David W. Kimmel, Larry K. Kvols et al. · Annals of Neurology · 1992 · 155 citations
Medicine, Neurology, Neuroscience +17
The Merck Manual of Diagnosis and Therapy
Frank Gray · JAMA · 1982 · 66 citations